These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1612228)

  • 1. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
    Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
    Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
    Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.
    Kawasaki E; Moriuchi R; Takino H; Okuno S; Takao Y; Maeda Y; Yokota A; Yamamoto H; Chikuba N; Akazawa S
    Diabetologia; 1992 Aug; 35(8):748-52. PubMed ID: 1511801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin autoantibodies as determined by competitive radiobinding assay are positively correlated with impaired beta-cell function--the Ulm-Frankfurt Population Study.
    Yassin N; Seissler J; Glück M; Boehm BO; Heinze E; Pfeiffer EF; Scherbaum WA
    Klin Wochenschr; 1991 Oct; 69(16):736-41. PubMed ID: 1762378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of incidental hyperglycemia and glycosuria of childhood.
    Schatz DA; Kowa H; Winter WE; Riley WJ
    J Pediatr; 1989 Nov; 115(5 Pt 1):676-80. PubMed ID: 2681635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin 2 receptor expression in post-gestational women: relationship to impaired glucose tolerance and islet cell antibodies in pregnancy.
    O'Brien CJ; Crockard AD; McMillan S; Rodgers L; Middleton D; Fay A; Harley JM; Hadden DR
    Autoimmunity; 1990; 7(2-3):97-108. PubMed ID: 2104186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients.
    Timsit J; Caillat-Zucman S; Blondel H; Chédin P; Bach JF; Boitard C
    Diabetologia; 1992 Aug; 35(8):792-5. PubMed ID: 1511808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.